Young Richard A — SEC Form 4 filings
SEC reporting owner CIK 1490283. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-07 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 31,529 shares, $52,023 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 34,837 shares, $178,365 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 34,837 shares @ $5.12 ($178,365) in Syros Pharmaceuticals, Inc., filed 2024-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. (SYRS) | Director | 3 | — | 1 leg · 34,837 sh · $178,365 | 4 |
| Camp4 Therapeutics Corp (CAMP) | Director | 5 | 2 legs · 31,529 sh · $52,023 | — | 4 |
| Omega Therapeutics, Inc. (OMGA) | Director | 1 | — | — | 1 |
Form 4 filings — Young Richard A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-05 | 4 | Camp4 Therapeutics Corp (CAMP) | Purchase (P): 16,378 @ $1.65 | EDGAR |
| 2026-06-12 | 4 | Camp4 Therapeutics Corp (CAMP) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | Camp4 Therapeutics Corp (CAMP) | Purchase (P): 15,151 @ $1.65 | EDGAR |
| 2025-06-27 | 4 | Camp4 Therapeutics Corp (CAMP) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | Camp4 Therapeutics Corp (CAMP) | Conversion (C): 8,917 · Conversion (C): 100,014 (derivative) | EDGAR |
| 2024-09-18 | 4 | Syros Pharmaceuticals, Inc. (SYRS) | Option exercise (M): 2,667 · Option exercise (M): 2,667 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Syros Pharmaceuticals, Inc. (SYRS) | Sale (S): 34,837 @ $5.12 | EDGAR |
| 2024-06-21 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1490283 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →